PHATHOM PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
PHATHOM PHARMACEUTICALS, INC. (PHAT) had Shares Outstanding (Cover Page) of 80.90 million shares as of 2026-07-27, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-07-27: Entity Common Stock, Shares Outstanding 80.90M shares.
- 2026-04-27: Entity Common Stock, Shares Outstanding 79.76M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 78.80M shares.
- 2025-10-27: Entity Common Stock, Shares Outstanding 71.14M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-27 | 80.90M shares 10-Q · filed 2026-07-30 |
| 2026-04-27 | 79.76M shares 10-Q · filed 2026-04-30 |
| 2026-02-23 | 78.80M shares 10-K · filed 2026-02-26 |
| 2025-10-27 | 71.14M shares 10-Q · filed 2025-10-30 |
| 2025-08-04 | 70.94M shares 10-Q · filed 2025-08-07 |
| 2025-04-29 | 69.81M shares 10-Q · filed 2025-05-01 |
| 2025-03-03 | 69.64M shares 10-K · filed 2025-03-06 |
| 2024-11-04 | 68.38M shares 10-Q · filed 2024-11-07 |
| 2024-08-06 | 59.59M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 58.54M shares 10-Q/A · filed 2024-06-14 |
| 2024-03-04 | 58.48M shares 10-K/A · filed 2024-06-14 |
| 2023-11-07 | 57.25M shares 10-Q · filed 2023-11-09 |
| 2023-08-08 | 56.80M shares 10-Q · filed 2023-08-10 |
| 2023-05-08 | 43.61M shares 10-Q · filed 2023-05-10 |
| 2023-02-24 | 41.97M shares 10-K · filed 2023-02-28 |
| 2022-11-07 | 41.62M shares 10-Q/A · filed 2022-11-09 |
| 2022-07-29 | 39.18M shares 10-Q · filed 2022-08-02 |
| 2022-05-04 | 39.07M shares 10-Q · filed 2022-05-10 |
| 2022-02-24 | 31.71M shares 10-K · filed 2022-03-01 |
| 2021-11-03 | 31.41M shares 10-Q · filed 2021-11-08 |
| 2021-08-05 | 31.36M shares 10-Q · filed 2021-08-10 |
| 2021-05-06 | 31.33M shares 10-Q · filed 2021-05-11 |
| 2021-03-26 | 31.32M shares 10-K · filed 2021-03-30 |
| 2020-11-06 | 28.96M shares 10-Q · filed 2020-11-10 |
| 2020-08-03 | 28.96M shares 10-Q · filed 2020-08-06 |
| 2020-05-05 | 28.96M shares 10-Q · filed 2020-05-12 |
| 2020-03-10 | 28.96M shares 10-K · filed 2020-03-19 |
| 2019-11-23 | 24.53M shares 10-Q · filed 2019-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |